FDA Allows Marketing of Test to Identify Organisms That Cause Bloodstream Infections and Provide Antibiotic Sensitivity Results

Kaye Donald

首页> 外文期刊>Clinical infectious diseases >FDA Allows Marketing of Test to Identify Organisms That Cause Bloodstream Infections and Provide Antibiotic Sensitivity Results

【24h】

FDA Allows Marketing of Test to Identify Organisms That Cause Bloodstream Infections and Provide Antibiotic Sensitivity Results

机译：FDA允许营销测试以鉴定导致血流感染并提供抗生素敏感性结果的生物

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical infectious diseases》 |2017年第11期|共1页
作者
Kaye Donald;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词

相似文献

外文文献
中文文献
专利

1. FDA Allows Marketing of Test to Identify Organisms That Cause Bloodstream Infections and Provide Antibiotic Sensitivity Results [J] . Kaye Donald Clinical infectious diseases . 2017,第11期

机译：FDA允许营销测试以鉴定导致血流感染并提供抗生素敏感性结果的生物
2. Nosocomial Bloodstream Infections in Children in Intensive Care Unit: Organisms, Sources, Their Sensitivity Pattern and Outcome of Treatment [J] . Syed Ahsan Tauhid, MAK Azad Chowdhury, Md Mahbubul Hoque, Journal of Bangladesh College of Physicians and Surgeons . 2017,第3期

机译：重症监护室儿童的医院血流感染：生物，来源，其敏感性模式和治疗结果
3. Heterogeneity in the treatment of bloodstream infections identified from antibiotic exposure mapping [J] . Caffrey Aisling R., Babcock Zachary R., Lopes Vrishali V., Pharmacoepidemiology and drug safety . 2019,第5期

机译：异质性在治疗抗生素暴露映射中鉴定的血流感染
4. Using metabolomic and transportomic modeling and machine learning to identify putative novel therapeutic targets for antibiotic resistant Pseudomonad infections [C] . Larsen Peter E., Collart Frank R., Dai Yang Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2014

机译：使用代谢组学和转运组学模型以及机器学习来确定抗生素耐药性假单胞菌感染的新型治疗靶标
5. The Influence of Polymicrobial Interactions on Antibiotic Sensitivity: Underlying Mechanisms and Potential Implications for Treating Chronic Infections [D] . Orazi, Giulia. 2019

机译：多发性相互作用对抗生素敏感性的影响：治疗慢性感染的潜在机制和潜在影响
6. 1052. Do Healthcare Providers De-Escalate β-Lactam (BL) Antibiotic Therapy Based on Results of Antibiotic Susceptibility Testing (AST)? Analysis of Bloodstream Infections (BSI) Caused by Escherichia coli and Klebsiella pneumoniae From the Veterans Health Administration (VHA) [O] . Roberto Viau, Brigid Wilson, Scott R Evans, -1

机译：1052.医疗保健提供者是否根据抗生素药敏试验（AST）的结果降低β-内酰胺（BL）抗生素的治疗水平？退伍军人卫生管理局（VHA）分析由大肠杆菌和肺炎克雷伯菌引起的血流感染（BSI）
7. 129. Antimicrobial Activity of Ceftazidime–avibactam and Comparator Agents Tested against Gram-Negative Organisms Isolated from Patients with Bloodstream Infections in United States Medical Centers (2017–2018) [O] . Cecilia G Carvalhaes, Mariana Castanheira, Rodrigo E Mendes, 2019

机译：129. CeTTazidime-Avibactam和比较剂对来自美国医疗中心的血流感染患者分离的革兰氏阴性生物进行测试的抗微生物活性（2017-2018）

FDA Allows Marketing of Test to Identify Organisms That Cause Bloodstream Infections and Provide Antibiotic Sensitivity Results

著录项

相似文献

相关主题

期刊订阅